Clinical trials recruiting for Pancreas Adenocarcinoma
19
Recruiting trials
6
US states with sites
9
Countries
11%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Massachusetts | 2 |
| California | 1 |
| Connecticut | 1 |
| New Hampshire | 1 |
| North Carolina | 1 |
| Texas | 1 |
Top cities
Boston, Massachusetts 2Austin, TX 78758, Texas 1Charlotte, North Carolina 1Danvers, Massachusetts 1Lebanon, New Hampshire 1Loma Linda, California 1New Haven, Connecticut 1San Antonio, Texas 1Winston-Salem, North Carolina 1
Self-screener
Recruiting trials
- 24BRO681 : Alternating Gnp and mFOLFIRINOX for BR-PDAC
- A Liquid Biopsy for Pancreatic Cancer Early-detection and Disease Monitoring
- Analyzing and Solving Exceptional Long-term Survivors in Solid Tumors With Poor Prognosis
- Assoc. of Genomic Polymorphisms With Cancer Cachexia in Subjects With Panc Adenocarcinoma
- Genetic Testing Decision Aid
- Improving Pancreatic Cancer Care by the Use of Computational Science and Technology
- NIR-Fluorescence Guided Surgical Resection of Neoadjuvant Treated Localized Pancreatic Cancer Using SGM-101
- Neoadjuvant vs Upfront Surgery for Resectable Pancreatic Cancer and Periampullary Cancer
- PACAREG: a Multicenter Registry Trial in Pancreatic Ductal Adencarcinoma
- Pancreatic Cancer and Synchronous Liver Metastases Resection Following Neoadjuvant FOLFIRINOX
- Para-aortic Lymph Node Metastasis in Resectable Pancreatic Cancer
- Para-aortic Lymphnodes Removal During Upfront Pancreaticoduodenectomy
- Predictive Risk Factors for Pancreatic Fistula After Pancreaticoduodenectomy
- Preventing Postoperative Complications in Patients Undergoing High-risk Pancreatoduodenectomy With a Bundle Approach Including Hydrocortisone, Octreotide, and the Teres Ligament Patch (PANENCA)
- Survival, Quality of Life and Resectability in Locally Advanced Pancreatic Cancer
- THE-0504 in Patients With Solid Tumors
- Testing the Combination of Two Approved Chemotherapy Drugs and Radiation Prior to Surgery in Localized Pancreatic Cancer
- This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors
- Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels
Related conditions
Trials recruiting for Pancreas Adenocarcinoma often also study these conditions. Each links to its own recruiting-trial list.
Pancreatic cancer 870Pancreas Cancer 86Pancreas Neoplasm 8Lung cancer 2180Triple-negative breast cancer 138Resectable Pancreatic Cancer 4Periampullary Cancer 9Pancreas Cyst 8Colorectal cancer 1359Breast cancer 2239
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Pancreas Adenocarcinoma trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.